Brief: Relmada Therapeutics - Increases Authorized Common Stock To 200 Million Shares From 150 Million
28/05/2026 22:28
BRIEF-Relmada Therapeutics - Increases Authorized Common Stock To 200 Million Shares From 150 Million May 28 (Reuters) - Relmada Therapeutics Inc RLMD.O:
RELMADA THERAPEUTICS - INCREASES AUTHORIZED COMMON STOCK TO 200 MILLION SHARES FROM 150 MILLION - SEC FILING
Further company coverage: RLMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Relmada Therapeutics
See all newsRelmada Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Relmada Therapeutics Q2 EPS USD -0.11
Relmada Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia As Chief Business Officer
Brief: Relmada Therapeutics - Increases Authorized Common Stock To 200 Million Shares From 150 Million